Skip to main content

Advertisement

SpringerLink
Log in

ASO Author Reflections: Impact of RAS Mutations on Total Neoadjuvant Therapy Outcomes in Rectal Cancer

  • ASO Author Reflections
  • Published:
Annals of Surgical Oncology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Garcia-Aguilar J, Patil S, Gollub MJ, et al. Organ preservation in patients with rectal adenocarcinoma treated with total neoadjuvant therapy. J Clin Oncol. 2022;40(23):2546–56.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  2. Sclafani F, Wilson SH, Cunningham D, et al. Analysis of KRAS, NRAS, BRAF, PIK3CA and TP53 mutations in a large prospective series of locally advanced rectal cancer patients. Int J Cancer. 2020;146(1):94–102.

    Article  CAS  PubMed  Google Scholar 

  3. Khan AQ, Kuttikrishnan S, Siveen KS, et al. RAS-mediated oncogenic signaling pathways in human malignancies. Semin Cancer Biol. 2019;54:1–13.

    Article  PubMed  Google Scholar 

  4. Oshiro T, Uehara K, Aiba T, Mukai T, Ebata T, Nagino M. Impact of RAS/BRAF mutation status in locally advanced rectal cancer treated with preoperative chemotherapy. Int J Clin Oncol. 2018;23(4):681–8.

    Article  CAS  PubMed  Google Scholar 

  5. Bedrikovetski S, Traeger L, Fitzsimmons T, et al. Association between RAS/BRAF mutations and complete response following total neoadjuvant therapy in patients with rectal cancer: a prospective multicentred study. Ann Surg Oncol. 2023. https://doi.org/10.1245/s10434-023-14722-7.

    Article  PubMed  Google Scholar 

Download references

Funding

No funding was received for this research.

Author information

Authors and Affiliations

  1. Colorectal Unit, Department of Surgery, Royal Adelaide Hospital, Adelaide, SA, Australia

    Luke Traeger MBBS, MTrauma & Tarik Sammour MBChB, FRACS, PhD

  2. Discipline of Surgery, Faculty of Health and Medical Sciences, School of Medicine, University of Adelaide, Adelaide, SA, Australia

    Sergei Bedrikovetski BHSc (Hons), PhD, Luke Traeger MBBS, MTrauma & Tarik Sammour MBChB, FRACS, PhD

Authors
  1. Sergei Bedrikovetski BHSc (Hons), PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Luke Traeger MBBS, MTrauma
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Tarik Sammour MBChB, FRACS, PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Sergei Bedrikovetski BHSc (Hons), PhD.

Ethics declarations

Disclosure

There are no conflicts of interest.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

This article refers to: Bedrikovetski S, Traeger L, Fitzsimmons T, et al. Association between RAS/BRAF mutations and complete response following total neoadjuvant therapy in patients with rectal cancer: a prospective multicentred study. Ann Surg Oncol. (2023). https://doi.org/https://doi.org/10.1245/s10434-023-14722-7.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Bedrikovetski, S., Traeger, L. & Sammour, T. ASO Author Reflections: Impact of RAS Mutations on Total Neoadjuvant Therapy Outcomes in Rectal Cancer. Ann Surg Oncol 31, 1692–1693 (2024). https://doi.org/10.1245/s10434-023-14826-0

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1245/s10434-023-14826-0

Search

Navigation